PKD2 and autosomal dominant polycystic kidney disease: Altered RyR2 function may trigger a series of molecular events resulting in the development of cardiovascular abnormalities observed in ADPKD patients with defective PKD2 (reviewed in Lemos and Ehrlich, 2018).